The New York Times Magazine published a riveting piece in its August 9 edition about the tensions that can develop between clinicians and researchers when unapproved drugs are considered for patient treatment, as we have seen with Covid-19. Rather than trying to summarize the article, we strongly encourage everyone to give it a close read. While Covid-19 has created an extraordinary situation, the issue of treatment versus research crops up in many different contexts.